A Randomized Controlled Double Blinding Study of Intradermal Acupuncture Treatment on Obesity

The recruitment status of this study is unknown because the information has not been verified recently.
Verified December 2006 by Wonkwang University.
Recruitment status was  Recruiting
Korea Institute of Oriental Medicine
Information provided by:
Wonkwang University
ClinicalTrials.gov Identifier:
First received: December 20, 2006
Last updated: NA
Last verified: December 2006
History: No changes posted

The purpose of this study is to determine whether intradermal acupuncture is effective and safe in the treatment of obesity.

Condition Intervention Phase
Device: Intradermal Acupuncture Treatment
Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double-Blind
Primary Purpose: Treatment
Official Title: Korea Institute of Oriental Medicine

Resource links provided by NLM:

Further study details as provided by Wonkwang University:

Primary Outcome Measures:
  • Bio-body impedance methods

Secondary Outcome Measures:
  • Cholesterol, Triglycerides, HDL LDL cholesterol

Estimated Enrollment: 180
Study Start Date: August 2006
Estimated Study Completion Date: December 2006
Detailed Description:

Recently the Studies of auricular acupuncture or Common Acupuncture on obesity have been conducted. Saam acupuncture, the Korean unique acupuncture, is famous with its high efficacy but not established by the scientific way yet. Thus, we tried a double-blind study on the effect of sa-am acupuncture on obesity using intradermal acupuncture.


Ages Eligible for Study:   20 Years to 50 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • BMI>25, regular menstruation, volunteer

Exclusion Criteria:

  • symptomatic obesity, acupuncture treatment within 3 months, >120kg, pregnancy or breast-feeding, hemophilia, dementia, mental illness, arrhythmia, liver cirrhosis, renal failure, pace maker, diabete mellitus, tuberculosis, steroid taker,
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00414505

Contact: Sung-chul Kim 82-62-670-6442 kscndl@hanmail.net

Korea, Republic of
Wonkwang University Hospital Recruiting
Gwangju, Korea, Republic of, 503-310
Sponsors and Collaborators
Wonkwang University
Korea Institute of Oriental Medicine
Study Director: Sung-chul Kim, Ph.D. Dept. of Acupuncture & Moxibustion, Wonkwang University Hospital
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00414505     History of Changes
Other Study ID Numbers: K06070
Study First Received: December 20, 2006
Last Updated: December 20, 2006
Health Authority: South Korea: Institutional Review Board

Additional relevant MeSH terms:
Nutrition Disorders
Body Weight
Signs and Symptoms

ClinicalTrials.gov processed this record on April 16, 2014